The K2 Principal Fund L.P.

All filings by The K2 Principal Fund L.P. on record concern Appili Therapeutics Inc. In total, 79 filings cover trades dated from 20 February 2020 to 29 November 2021.

On the open market, the record shows 56 purchases worth €689k and 21 sales worth €325k. The net balance comes to €365k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2021, the count stands at 14 purchases and 5 sales.

The median purchase comes to €4,250. None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The record was last updated on 29 November 2021 with an open-market sale (€25k) in Appili Therapeutics Inc. The latest purchase dates back some time: it was published 1,933 days ago, on 9 July 2021. The median gap between a trade and its publication by SEDI is 2 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.